Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model

GSK2140944 is a novel bacterial type II topoisomerase inhibitor with in vitro activity against key causative respiratory pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). We described the pharmacodynamics of GSK2140944 against MRSA in the neutropenic murine lung infection mode...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: So, Wonhee, Crandon, Jared L., Nicolau, David P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2015
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505212/
https://ncbi.nlm.nih.gov/pubmed/26055376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00625-15
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items